Trafa Pharmaceutical Inc. Organic Moringa Leaf Powder Recall
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Trafa Pharmaceutical Inc. is recalling 500 kg of Organic Moringa Leaf Powder due to potential Salmonella contamination.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 8, 2026 and geographically references NY. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, food.
What Happened
Trafa Pharmaceutical Inc. initiated a voluntary recall of its Organic Moringa Leaf Powder because the product may be contaminated with Salmonella.
Which Products Are Affected
The recall involves Trafa Pharmaceuticals Inc. brand ORGANIC MORINGA LEAF POWDER, net weight 15 KGS, packaged in brown paper bags with a white label. Affected quantity is 500 kg. Batch information: BATCH #TRF-2025050801, MAN. DATE: 2025-05-08, RESTEST. DATE: 2028-05-07. Distribution was limited to NY. Recall number: H-1144-2026.
What You Should Do
Consumers in possession of the recalled product should not consume it. Contact Trafa Pharmaceutical Inc. for return or refund instructions.
Why This Matters
This Class I recall addresses a potential serious health risk from Salmonella contamination in a food product distributed in New York.
Source
FDA recall H-1144-2026 (event ID 99314).
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (897 characters here).
Similar severity timing
Same severity (high) notices issued closest in time to August 8, 2026.
Frequently Asked Questions
Common questions about this FDA recall.